A Clinical Investigation of a Topical Moisturizer on Skin Barrier Function in Adults With Sensitive Skin

Part of paid clinical trials in New York, New York.

Sponsor
Good Molecules, LLC
Study ID
NCT07811531
Phase
PHASE4
Status
Recruiting

Conditions

  • Sensitive Skin

Eligibility Criteria

Sex
ALL
Age
18 Years - 55 Years
Healthy Volunteers
Not accepted

Interventions

  • White petrolatum — OTHER
    Dose per Application: 6 full pumps per application to the assigned forearm.
  • Investigational moisturizer — OTHER
    Dose per Application: 6 full pumps per application to the assigned forearm.

Study Details

The purpose of this research study is to evaluate whether a marketed moisturizing cream can improve skin barrier function (how well the outer layer of the skin keeps moisture in and protects the skin), skin hydration, skin sensitivity, inflammatory biomarkers (proteins in the skin that can provide information about inflammation), and the skin microbiome (the microorganisms that naturally live on the skin) in adults with sensitive skin, when compared with a commonly used moisturizing ointment (White Petrolatum) a widely used occlusive ointment (an ointment that forms a protective layer over the skin to help reduce moisture loss).

Key Dates

First listed
Sep 10, 2026
Start date
Sep 14, 2026
Status verified
Sep 2026
Primary completion
Dec 16, 2026
Completion
Jan 12, 2027

Study Design

Enrollment
24 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Placebo Comparator: Occlusive comparator control
    White Petrolatum, USP
  • Experimental: Investigational moisturizer
    Marketed Moisturizer

Primary Outcome Measure

Transepidermal Water Loss (TEWL) [ Time Frame: Baseline and Day 28 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Sequential SkinNew YorkNew York10001
Dashi, PhD
+1 (646) 663-5260

Find similar trials in New York, NY